BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36759362)

  • 1. Single-time-point dosimetry using model selection and nonlinear mixed-effects modelling: a proof of concept.
    Hardiansyah D; Riana A; Beer AJ; Glatting G
    EJNMMI Phys; 2023 Feb; 10(1):12. PubMed ID: 36759362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based model selection for an accurate estimation of time-integrated activity using non-linear mixed-effects modelling.
    Hardiansyah D; Riana A; Eiber M; Beer AJ; Glatting G
    Z Med Phys; 2023 Feb; ():. PubMed ID: 36813594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [
    Hardiansyah D; Yousefzadeh-Nowshahr E; Kind F; Beer AJ; Ruf J; Glatting G; Mix M
    J Nucl Med; 2024 Apr; 65(4):566-572. PubMed ID: 38423787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-time-point estimation of absorbed doses in PRRT using a non-linear mixed-effects model.
    Hardiansyah D; Riana A; Beer AJ; Glatting G
    Z Med Phys; 2023 Feb; 33(1):70-81. PubMed ID: 35961809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based method to determine the time-integrated activity in molecular radiotherapy.
    Hardiansyah D; Riana A; Kletting P; Zaid NRR; Eiber M; Pawiro SA; Beer AJ; Glatting G
    EJNMMI Phys; 2021 Dec; 8(1):82. PubMed ID: 34905131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for
    Peterson AB; Mirando DM; Dewaraja YK
    EJNMMI Res; 2023 Jun; 13(1):57. PubMed ID: 37306783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in clinical patients and realistic simulations.
    Peterson AB; Mirando DM; Dewaraja YK
    Res Sq; 2023 Apr; ():. PubMed ID: 37131738
    [No Abstract]   [Full Text] [Related]  

  • 8. Single-Time-Point Imaging for Dosimetry After [
    Wang C; Peterson AB; Wong KK; Roseland ME; Schipper MJ; Dewaraja YK
    J Nucl Med; 2023 Sep; 64(9):1463-1470. PubMed ID: 37500260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncertainty Analysis of Time-Integrated Activity Coefficient in Single-Time-Point Dosimetry Using Bayesian Fitting Method.
    Jundi AF; Naqiyyun MD; Patrianesha BB; Mu'minah IAS; Riana A; Hardiansyah D
    Nucl Med Mol Imaging; 2024 May; 58(3):120-128. PubMed ID: 38633290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies.
    Hou X; Brosch J; Uribe C; Desy A; Böning G; Beauregard JM; Celler A; Rahmim A
    J Nucl Med; 2021 Jul; 62(7):1006-1011. PubMed ID: 33127625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Time-Activity Information-Sharing Approach Using Nonlinear Mixed Models for Patient-Specific Dosimetry with Reduced Imaging Time Points: Application in SPECT/CT After
    Devasia TP; Dewaraja YK; Frey KA; Wong KK; Schipper MJ
    J Nucl Med; 2021 Aug; 62(8):1118-1125. PubMed ID: 33443063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized radiation dosimetry for PRRT-how many scans are really required?
    Freedman N; Sandström M; Kuten J; Shtraus N; Ospovat I; Schlocker A; Even-Sapir E
    EJNMMI Phys; 2020 May; 7(1):26. PubMed ID: 32394075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simulation-based method to determine optimal sampling schedules for dosimetry in radioligand therapy.
    Rinscheid A; Lee J; Kletting P; Beer AJ; Glatting G
    Z Med Phys; 2019 Dec; 29(4):314-325. PubMed ID: 30611606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonlinear mixed-effects modeling of MNREAD data.
    Cheung SH; Kallie CS; Legge GE; Cheong AM
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):828-35. PubMed ID: 18235034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonlinear mixed-effects (NLME) diameter growth models for individual China-Fir (Cunninghamia lanceolata) trees in Southeast China.
    Xu H; Sun Y; Wang X; Fu Y; Dong Y; Li Y
    PLoS One; 2014; 9(8):e104012. PubMed ID: 25084538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of sampling schedules on [
    Rinscheid A; Kletting P; Eiber M; Beer AJ; Glatting G
    EJNMMI Phys; 2020 Jun; 7(1):41. PubMed ID: 32556844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular radiotherapy: the NUKFIT software for calculating the time-integrated activity coefficient.
    Kletting P; Schimmel S; Kestler HA; Hänscheid H; Luster M; Fernández M; Bröer JH; Nosske D; Lassmann M; Glatting G
    Med Phys; 2013 Oct; 40(10):102504. PubMed ID: 24089925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach.
    Michelet R; Bindellini D; Melin J; Neumann U; Blankenstein O; Huisinga W; Johnson TN; Whitaker MJ; Ross R; Kloft C
    Front Pharmacol; 2022; 13():1090554. PubMed ID: 36712688
    [No Abstract]   [Full Text] [Related]  

  • 19. Three-dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy.
    Baechler S; Hobbs RF; Boubaker A; Buchegger F; He B; Frey EC; Sgouros G
    Med Phys; 2012 Oct; 39(10):6118-28. PubMed ID: 23039651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a
    Zhao W; Esquinas PL; Frezza A; Hou X; Beauregard JM; Celler A
    Phys Med Biol; 2019 Aug; 64(17):175006. PubMed ID: 31287093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.